- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Case Study Spotlights FCS as a Top-Ranking Performer in the Oncology Care Model
A recently published case study by Florida Cancer Specialists & Research Institute showcased the practice’s multi-year track record of delivering savings as a participant in the Oncology Care Model (OCM) when compared with OCM and non-OCM practices nationally.
Fort Myers, Florida — A recently published case study by Florida Cancer Specialists & Research Institute (FCS) showcased the practice’s multi-year track record of delivering savings as a participant in the Oncology Care Model (OCM) when compared with OCM and non-OCM practices nationally.
Amongst more than 125 participating practices nationwide, FCS emerged as a leader in value-based care oncology in having successfully reduced Medicare expenditures by nearly $170 million in aggregate.
“Our success in this program is indicative of the resources, dedication, investment and overall integrity of FCS’ commitment to healthcare reform,” said Michael Diaz, MD, president and managing physician, FCS. “Patients can find reassurance knowing that we have put elaborate measures in place to not only utilize state of the art technologies and therapeutics to maximize treatment outcomes but optimize care delivery to positively influence their overall cancer journey.”
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
